top of page

Axon Therapy mPNS is shown in clinical studies to reduce pain in eligible pateints

FDA-cleared, pain-free treatment for chronic neuropathic pain.

faxOzLMA_edited.jpg

No leads.

No injections.

No implants.

No risk of infection.

No interruptions due to leads or batteries.

The treatment is simple. The results can be profound.

The only FDA-cleared mPNS treatment for chronic pain relife.

bCc5IlJg.png

One year study of Axon Therapy mPNS

65 patients:
At 1 year -
94% responders
(>50% pain relief)

62.5% patients were profound responders
(>80% pain relief)

No serious adverse events

bottom of page